Done sou Salè H1B

Akèy › Anplwayè › Public Health Institute

Public Health Institute: Salè H-1B ak pajon

Public Health Institute depoze 4 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 4. Medyèn salè yo ofri a: $128,618.

Demann (LCA)4
Certifye4
Adrès anplwayèOakland, CA
Anplwayè H-1B depannNon
Salè medyan ofri$128,618
Mwatye salè yo$106,483–$151,856
10yèm–90yèm pousantaj$104,731–$155,590

Èske Public Health Institute pajone visa H-1B?

Public Health Institute depoze 4 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Mar 24, 2025. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.

Salè pa tit travay

Tit travayLCASalè medyan
Biostatistician II2$105,510
Senior PeopleSoft Engineer1$158,080
Sr. PeopleSoft Engineer II1$149,781

Aplikasyon pa ane fiskal

Ane fiskalLCASalè medyan
FY20232$130,822
FY20241$107,456
FY20251$149,781

Nivo salè prevanlan

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Kote travay yo ye

Okipasyon

Dènye aplikasyon yo

Tit travaySalè bazKoteSoumètDat kòmansmanEstati
Sr. PeopleSoft Engineer II$149,781–$225,289
Nivo IV
Prosper, TXMar 24, 2025Jul 22, 2025Certifye
Biostatistician II$107,456–$153,320
Nivo II
Hoover, ALJun 18, 2024Aug 3, 2024Certifye
Biostatistician II$103,563–$159,181
Nivo II
Emeryville, CAMar 20, 2023Jun 12, 2023Certifye
Senior PeopleSoft Engineer$158,080
Nivo III
Oakland, CAJan 19, 2023Feb 3, 2023Certifye

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).